LLY

1,040.23

-1.02%↓

JNJ

251.28

+1.15%↑

ABBV

232.17

+0.08%↑

NVS

167.39

-0.55%↓

MRK

122.8

-0.74%↓

LLY

1,040.23

-1.02%↓

JNJ

251.28

+1.15%↑

ABBV

232.17

+0.08%↑

NVS

167.39

-0.55%↓

MRK

122.8

-0.74%↓

LLY

1,040.23

-1.02%↓

JNJ

251.28

+1.15%↑

ABBV

232.17

+0.08%↑

NVS

167.39

-0.55%↓

MRK

122.8

-0.74%↓

LLY

1,040.23

-1.02%↓

JNJ

251.28

+1.15%↑

ABBV

232.17

+0.08%↑

NVS

167.39

-0.55%↓

MRK

122.8

-0.74%↓

LLY

1,040.23

-1.02%↓

JNJ

251.28

+1.15%↑

ABBV

232.17

+0.08%↑

NVS

167.39

-0.55%↓

MRK

122.8

-0.74%↓

Home・Akcijų sąrašas・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

27.77 -2.46

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

27.85

Max

28.65

Pagrindiniai rodikliai
By Trading Economics
Pajamos	11M 51M
Pardavimai	39M 239M
P/E Sektoriaus vid.	8.476 108.767
Pelnas, tenkantis vienai akcijai	1.08
Pelno marža	21.242
Darbuotojai	268
EBITDA	14M 73M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+44.53% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-05

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-140M 1.5B
Ankstesnė atidarymo kaina	30.23
Ankstesnė uždarymo kaina	27.77

Naujienos nuotaikos

By Acuity

50%

154 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

29.8 / N/A Palaikymas ir pasipriešinimas

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-01 23:35; UTC

Svarbiausios naujienos

Oil Prices Jump in Asia as U.S.-Iran Conflict Stokes Supply Fears -- Energy Comment

2026-03-01 23:49; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Australian Gold-Mining Stocks Rally as Attack on Iran Drives Gold Higher -- Market Talk

2026-03-01 23:47; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold, Silver Rise as Middle East Conflict Spurs Safe-Haven Demand -- Market Talk

2026-03-01 23:41; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Lasting Oil Price Shock Could Stoke Global Inflation -- Market Talk

2026-03-01 23:39; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-01 23:39; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Nikkei May Fall Amid Concerns About Higher Energy Prices -- Market Talk

2026-03-01 23:36; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Jumps as Middle East Conflict Heightens Supply Disruption Concerns -- Market Talk

2026-03-01 23:24; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-03-01 23:24; UTC

Rinkos pokalbiai

Financial Markets Trim Bets on RBA Hike in May -- Market Talk

2026-03-01 23:21; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-01 23:21; UTC

Rinkos pokalbiai

Sky Network TV's Risk/Reward Still Not Attractive -- Market Talk

2026-03-01 23:19; UTC

Svarbiausios naujienos

Front-Month Brent Crude Oil Futures Rose 8.5% to $79.08/bbl

2026-03-01 23:17; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Rose 8.4% to $72.65/bbl

2026-03-01 23:14; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Extend Gains in Early Trade

2026-03-01 22:55; UTC

Svarbiausios naujienos

Spot Gold Rises 1.9% to $5,278.61/oz Amid Middle East Conflict

2026-03-01 22:54; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Rise Amid Middle East Conflict

2026-03-01 22:53; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Rise 3.2% to $67.29/bbl

2026-03-01 22:38; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Attack on Iran Likely to Push Up Floor Under Gold -- Market Talk

2026-03-01 22:21; UTC

Uždarbis

Berkshire's Earnings Weren't as Bad as They Looked. A Goodwill Write-Down Hit Operating Profits. -- Barrons.com

2026-03-01 22:17; UTC

Rinkos pokalbiai

Financial Markets Trim Bets On RBA Hike In May -- Market Talk

2026-03-01 22:13; UTC

Rinkos pokalbiai

Svarbiausios naujienos

OPEC+ Oil Output Boost Could Be Moot if Strait of Hormuz Unavailable -- Market Talk

2026-03-01 22:00; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Could Surge Above $100 If Flows Don't Return to Normal Quickly -- Market Talk

2026-03-01 21:40; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Spot Gold Up as Investors Shield Against Risk -- Market Talk

2026-03-01 21:35; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Prices Seen Rising to Low to Mid-US$80s Per Barrel -- Market Talk

2026-03-01 21:30; UTC

Rinkos pokalbiai

Australian Dollar Weakens Most as Trader Fear Long-Term Conflict -- Market Talk

2026-03-01 21:27; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Prices Likely to Rise on Iran Conflict But to Manageable Levels -- Market Talk

2026-03-01 21:19; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Shipping Disruptions 'More Acute Risk' Than Oil Output From Iran Conflict -- Market Talk

2026-03-01 20:58; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Risk Off Stance in Markets Amid Fears of Wider Conflict -- Market Talk

2026-03-01 20:40; UTC

Rinkos pokalbiai

Australia Dollar to Fall Sharply Against U.S. Dollar on Middle East Conflict -- Market Talk

2026-03-01 20:24; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Brent Crude at $100/bbl Could Slow Pace of Global Rate Cuts -- Market Talk

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

44.53% į viršų

12 mėnesių prognozė

Vidutinis 41.25 USD 44.53%

Aukščiausias 62 USD

Žemiausias 25 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

8 ratings

Pirkti

Laikyti

Parduoti

Remiantis 8 analitikų, pateikusių Harmony Biosciences Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

154 / 352 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.